Farnum Rhonda: insider trades.
Farnum Rhonda reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($227K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Farnum Rhonda
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | Officer · SVP, COMM & MEDICAL AFFAIRS | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Theravance Biopharma, Inc. | D | 89,062 | — | 0 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 124,414 | — | 89,062 | Form 4 |
| 2026-09-15 | Theravance Biopharma, Inc. | S | 3,328 | $17.03 | 220,133 | Form 4 |
| 2026-09-15 | Theravance Biopharma, Inc. | S | 6,657 | $17.03 | 213,476 | Form 4 |
| 2026-09-15 | Theravance Biopharma, Inc. | S | 3,329 | $17.03 | 223,461 | Form 4 |
| 2026-08-20 | Theravance Biopharma, Inc. | F | 5,667 | $16.95 | 226,790 | Form 4 |
Questions
What stock did Farnum Rhonda buy or sell?
Farnum Rhonda reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($227K), across 1 company.
Is Farnum Rhonda the same person as other filers with this name?
This page covers SEC CIK 1898490 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/farnum-rhonda-1898490.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.